TIME picks an X-ray system that makes 3D views with up to 80% less radiation than CT for the same body parts.
Nanox Imaging Ltd. (NASDAQ: NNOX) announced that its Nanox.ARC X system was selected as one of TIME’s Best Inventions of 2026. The system offers 3D imaging with up to 80% less radiation than CT scans. This is Nanox’s second appearance on TIME’s list, marking its first inclusion on the main list. The company plans to showcase the system at the RSNA 2026 Annual Meeting.
How this was made
The 30-second read
Why it matters
The accolade could enhance brand credibility and drive interest from imaging centers, but actual sales growth depends on market adoption and reimbursement.
Market read
A niche but positive catalyst for Nanox; limited spillover to the broader med‑tech sector.
What to watch
Potential regulatory or reimbursement hurdles for the new system could temper upside.
Background
Nanox announced its Nanox.ARC X system was selected by TIME as a 2026 Best Invention, emphasizing reduced radiation and 3D imaging capability.
Ticker impact
Nanox Imaging Ltd. (NASDAQ:NNOX) was announced as a TIME Best Inventions 2026 selection for its Nanox.ARC X system.
likely modest upward pressure as investors price in increased market awareness
The award is a fresh, primary disclosure but limited in scale; impact is expected to be incremental rather than transformative.
Market effects
Highlights growing interest in low‑radiation imaging, potentially benefiting the broader medical imaging sector.
May raise visibility for U.S. and Israeli med‑tech innovators.
Limited to niche imaging market; no broad macro effect.
Counterpoint
The award may be largely symbolic with little immediate revenue impact; investors should wait for concrete sales data.
Key entities
- companyNanox Imaging Ltd.
Developer of the Nanox.ARC X low‑radiation imaging system.
- mediaTIME Magazine
Publisher of the Best Inventions list.
